Impacts of papain and neuraminidase enzyme treatment on electrohydrodynamics and IgG-mediated agglutination of type A red blood cells.
The stability of native and enzyme-treated human red blood cells of type A (Rh D positive) against agglutination is investigated under conditions where it is mediated by immunoglobuline G (IgG) anti-D antibody binding. The propensity of cells to agglutinate is related to their interphasic (electrokinetic) properties. These properties significantly depend on the concentration of proteolytic papain enzyme and protease-free neuraminidase enzyme that the cells are exposed to. The analysis is based on the interpretation of electrophoretic data of cells by means of the numerical theory for the electrokinetics of soft (bio)particles. A significant reduction of the hydrodynamic permeability of the external soft glycoprotein layer of the cells is reported under the action of papain. This reflects a significant decrease in soft surface layer thickness and a loss in cell surface integrity/rigidity, as confirmed by nanomechanical AFM analysis. Neuraminidase action leads to an important decrease in the interphase charge density by removing sialic acids from the cell soft surface layer. This is accompanied by hydrodynamic softness modulations less significant than those observed for papain-treated cells. On the basis of these electrohydrodynamic characteristics, the overall interaction potential profiles between two native cells and two enzyme-treated cells are derived as a function of the soft surface layer thickness in the Debye-Hückel limit that is valid for cell suspensions under physiological conditions (approximately 0.16 M). The thermodynamic computation of cell suspension stability against IgG-mediated agglutination then reveals that a decrease in the cell surface layer thickness is more favorable than a decrease in interphase charge density for inducing agglutination. This is experimentally confirmed by agglutination data collected for papain- and neuraminidase-treated cells.
Hyono
Atsushi
A
Faculty of Pharmaceutical Science, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan.
Gaboriaud
Fabien
F
Mazda
Toshio
T
Takata
Youichi
Y
Ohshima
Hiroyuki
H
Duval
Jérôme F L
JF
D000017:ABO Blood-Group System / Q000276:immunology / Q000378:metabolism; D004912:Erythrocytes / Q000276:immunology* / Q000378:metabolism*; D006384:Hemagglutination / Q000276:immunology*; D006386:Hemagglutination Tests; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology*; D008954:Models, Biological; D009439:Neuraminidase / Q000378:metabolism*; D010206:Papain / Q000378:metabolism*; D012204:Rh-Hr Blood-Group System / Q000276:immunology; D055672:Static Electricity; D013816:Thermodynamics
D000017:ABO Blood-Group System; D007074:Immunoglobulin G; D012204:Rh-Hr Blood-Group System; D009439:Neuraminidase; D010206:Papain